Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Viral Infection”

476 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 476 results

Very early researchNot Yet RecruitingNCT06908018
What this trial is testing

Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune)

Who this might be right for
Safety IssuesDengueViremia+1 more
Mahidol University 12
Not applicableStudy completedNCT04963166
What this trial is testing

Natural History of Systemic and Nasal Mucosal Immunity After Influenza Vaccination in a Pediatric Population

Who this might be right for
Influenza Immunity
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT01782209
What this trial is testing

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

Who this might be right for
BK Virus (BKV) Viremia
University of Alabama at Birmingham 335
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Not applicableUnknownNCT04810364
What this trial is testing

HIV Infection And Evolvement of Atherosclerotic Plaque

Who this might be right for
Coronary Artery DiseaseAtherosclerosis, CoronaryHiv+2 more
Central Clinical Hospital of the Russian Academy of Sciences 1,000
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Post-approval studies (Phase 4)Active Not RecruitingNCT07232745
What this trial is testing

Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 60
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Not applicableLooking for participantsNCT06657781
What this trial is testing

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Who this might be right for
Bacterial Sepsis
Centre Hospitalier Universitaire de la Guadeloupe 171
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT00310128
What this trial is testing

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Who this might be right for
AIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell Lymphoma
AIDS Malignancy Consortium
Not applicableNo Longer AvailableNCT04355793
What this trial is testing

Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection

Who this might be right for
COVID-19
Incyte Corporation
Not applicableStudy completedNCT05148832
What this trial is testing

Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19

Who this might be right for
COVID-19Olfactory Dysfunction
Fayoum University 80
Not applicableLooking for participantsNCT05934149
What this trial is testing

Lupus Landmark Study: A Prospective Registry and Biorepository

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus
Lupus Research Alliance 3,500
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Testing effectiveness (Phase 2)Study completedNCT04351243
What this trial is testing

Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Who this might be right for
COVID-19
Kinevant Sciences GmbH 227
Not applicableStudy completedNCT04346017
What this trial is testing

Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome

Who this might be right for
COVID-19
Francis Corazza 63
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05350774
What this trial is testing

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

Who this might be right for
Systemic InflammationNeuroinflammationMicrovascular Thrombosis
National Institute of Neurological Disorders and Stroke (NINDS) 45
Not applicableStudy completedNCT02024282
What this trial is testing

Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care

Who this might be right for
SepsisBacteraemiaMeningitis+7 more
KU Leuven 8,962
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Next Page